Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: Distinctive parameters of HIV-induced change (Q44646076)

5 December 2017

Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: Distinctive parameters of HIV-induced change (English)

1 reference

https://api.crossref.org/works/10.1016/S0090-1229(05)80025-X

27 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0090-1229(05)80025-X

27 October 2022

author name string

B. Hofmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1680589

27 October 2022

P. Nishanian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1680589

27 October 2022

J. L. Fahey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1680589

27 October 2022

I. Esmail

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1680589

27 October 2022

A. L. Jackson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1680589

27 October 2022

R. Detels

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1680589

27 October 2022

W. Cumberland

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1680589

27 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1680589

27 October 2022

publication date

1 November 1991

1 reference

full work available at URL

5 December 2017

https://api.elsevier.com/content/article/PII:S009012290580025X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0090-1229(05)80025-X

https://api.elsevier.com/content/article/PII:S009012290580025X?httpAccept=text/plain

27 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0090-1229(05)80025-X

Clinical Immunology and Immunopathology

27 October 2022

published in

1 reference

5 December 2017

61

1 reference

5 December 2017

2 Pt 1

1 reference

5 December 2017

212-224

1 reference

Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

Interleukin 2 high-affinity receptor expression requires two distinct binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

Restricted expression of p55 interleukin 2 receptor (CD25) on normal T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

In vitro activation of T lymphocytes from human immunodeficiency virus (HIV)-seropositive blood donors. I. Soluble interleukin 2 receptor (IL2R) production parallels cellular IL2R expression and DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

Immunological studies in acquired immunodeficiency syndrome. Functional studies of lymphocyte subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

Immunological studies of homosexual men with immunodeficiency and Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

Elevated soluble interleukin-2 receptor levels in serum of human immunodeficiency virus infected populations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprises

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

Adoptive immunotherapy with interleukin-2 (IL-2) results in diminished IL-2 production by stimulated peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

Investigation of immunosuppressive properties of inactivated human immunodeficiency virus and possible neutralization of this effect by some patient sera

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980025-X

7 January 2021

A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells

4

1 reference

https://api.crossref.org/works/10.1016/S0090-1229(05)80025-X

HIV inhibits the early steps of lymphocyte activation, including initiation of inositol phospholipid metabolism

27 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/S0090-1229(05)80025-X

27 October 2022

Identifiers

1 reference

5 December 2017

1 reference